ESCRS: NTC presented the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade

  • Sep 24, 2018

NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade.

Rationalization of prescriptive behaviors in ophthalmology for the containment of antibiotic resistance

  • Sep 03, 2018

On September 22 nd, during the ESCRS Congress in Wien, NTC organizes a Satellite Symposium: "Rationalization of prescriptive behaviours in ophthalmology for the containment of antibiotic resistance".

Mundipharma extends partnership with NTC for licensing and distribution rights for ophthalmology portfolio into Latin America

  • Jul 25, 2018

Mexico City, 25 July 2018: Mundipharma has expanded its ophthalmology portfolio in Latin America by agreeing a new commercial partnership with NTC – an Italian pharmaceutical company with deep experience in research and development – for exclusive rights to license and distribute a range of ophthalmic medicines across the region...

NTC to strengthen its ophthalmology portfolio through the acquisition of ocular antibiotic products

  • May 31, 2018

The company anticipates the next opening of a branch in Spain, with a broad portfolio of quality products. 

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. READ MORE